1. 166 Efficacy of Dupilumab in Children With Uncontrolled, Moderate-to-Severe Type 2 Asthma, With and Without Evidence of Allergy Enrolled in Phase 3 VOYAGE. (11th October 2021) Authors: Szefler, Stanley J; Bacharier, Leonard B; Maspero, Jorge F; Papadopoulos, Nikos; Domingo, Christian; Daizadeh, Nadia; Lederer, David J; Hardin, Megan; Jacob-Nara, Juby A; Deniz, Yamo; Gall, Rebecca; Ortiz, Benjamin; Djandji, Michel; Rowe, Paul J Journal: Archives of disease in childhood Issue: Volume 106(2021)Supplement 2 Page Start: A70 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 230. ENDOSCOPIC REFERENCE SCORE REMODELING SUBSCORE AND ESOPHAGEAL EOSINOPHIL COUNT DO NOT CORRELATE IN PLACEBO-TREATED EOSINOPHILIC ESOPHAGITIS PATIENTS FROM DUPILUMAB STUDIES. (24th September 2022) Authors: Hirano, Ikuo; Rothenberg, Marc E; Spergel, Johnathan M; Aceves, Seema; Greenhawt, Matthew; Schoepfer, Alain M; Philpott, Hamish; Chen, Zhen; Radwan, Amr; Khodzhayev, Angela; Deniz, Yamo; Rowe, Paul J; Pela, Tiffany; Jacob-Nara, Juby A Journal: Diseases of the esophagus Issue: Volume 35(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 233. ENDOSCOPIC REFERENCE SCORE AND HISTOLOGICAL SCORING SYSTEM ARE COMPLEMENTARY ASSESSMENTS FOR CHARACTERIZING FIBROSTENOTIC OR INFLAMMATORY PHENOTYPES IN EOSINOPHILIC ESOPHAGITIS PATIENTS. (24th September 2022) Authors: Collins, Margaret H; Rothenberg, Marc E; Bredenoord, Albert J; Wechsler, Joshua; Chehade, Mirna; Philpott, Hamish; Chen, Zhen; Radwan, Amr; Pela, Tiffany; Khodzhayev, Angela; Jacob-Nara, Juby A; Deniz, Yamo; Rowe, Paul J Journal: Diseases of the esophagus Issue: Volume 35(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis. Issue 10 (October 2021) Authors: Busse, William W; Wenzel, Sally E; Casale, Thomas B; FitzGerald, J Mark; Rice, Megan S; Daizadeh, Nadia; Deniz, Yamo; Patel, Naimish; Harel, Sivan; Rowe, Paul J; Graham, Neil M H; O'Riordan, Thomas; Pavord, Ian D Journal: Lancet Issue: Volume 9:Issue 10(2021) Page Start: 1165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study. Issue 1 (January 2022) Authors: Wechsler, Michael E; Ford, Linda B; Maspero, Jorge F; Pavord, Ian D; Papi, Alberto; Bourdin, Arnaud; Watz, Henrik; Castro, Mario; Nenasheva, Natalia M; Tohda, Yuji; Langton, David; Cardona, Guido; Domingo, Christian; Park, Hae Sim; Chapman, Kenneth R; Mao, Xuezhou; Zhang, Yi; Khan, Asif H; Deniz,... Journal: Lancet Issue: Volume 10:Issue 1(2022) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗